OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Release Date
2022
(4)
2023
(3)
2025
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Evaluation of the whole proteome to design a novel mRNA-based vaccine against multidrug-resistant
Serratia marcescens
.
Not available
S-EPMC9624125
|
biostudies-literature
Cite
HPLC, FTIR and GC-MS Analyses of
Thymus vulgaris
Phytochemicals Executing In Vitro and In Vivo Biological Activities and Effects on
COX-1
,
COX-2
and Gastric Cancer Genes Computationally.
Not available
S-EPMC9736827
|
biostudies-literature
Cite
Epidemiology, Clinico-Pathological Characteristics, and Comorbidities of SARS-CoV-2-Infected Pakistani Patients.
Not available
S-EPMC9226825
|
biostudies-literature
Cite
Determinants of Implementation of a Critical Care Registry in Asia: Lessons From a Qualitative Study.
Not available
S-EPMC10028509
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10156147
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets